Complementation of the genetic defect in Gunn rat hepatocytes in vitro by highly efficient gene transfer with cationic liposomes

Gene Therapy

Volumn 4, Issue 12, 1997, Pages 1305-1312

  Wilke, M ^a,d   Bijma, A ^b   Timmers Reker, A J T ^a   Scholte, B J ^c   Sinaasappel, M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d Building 1E3 Q ^*  (Netherlands)

Author keywords

Crigler Najjar disease; Gene therapy; Hepatocyte culture; Nonviral vectors; Proliferation; Transfection

Indexed keywords

BETA GALACTOSIDASE; BILIRUBIN; DEXAMETHASONE; GROWTH FACTOR; LIPOSOME; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIRUBIN BINDING; CELL VIABILITY; CONTROLLED STUDY; CRIGLER NAJJAR SYNDROME; CYTOMEGALOVIRUS; DNA TRANSFECTION; EXPRESSION VECTOR; GENE TRANSFER; GENETIC COMPLEMENTATION; GENETIC DISORDER; INTRON; LIVER CELL CULTURE; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; ROUS SARCOMA ONCOVIRUS;

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; ONCOVIRINAE; RATTUS NORVEGICUS; RICE STRIPE VIRUS; ROUS SARCOMA VIRUS;

EID: 0031436819     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300542     Document Type: Article

References (40)

1. Grossman M et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet 1994; 6: 335-341.
2. Fallaux FJ, Hoeben RC, Briet E. State and prospects of gene therapy for the hemophilias. Thromb Haemosiasis 1995; 74: 266-273.
3. Crigler J, Najjar V. Congenital nonhemolytic jaundice with kernicterus. Pediatrics 1952; 10: 169-170.
4. Sinaasappel M, Jansen PL. The differential diagnosis of Crigler-Najjar disease, types 1 and 2, by bile pigment analysis. Gastroenterology 1991; 100: 783-789.
5. Seppen J et al. Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest 1994; 94: 2385-2391.
6. Seppen J et al. A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes CriglerNajjar type II. FEBS Lett 1996; 390; 294-298.
7. Ritter JK et al. Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type 1 patient J Clin Invest 1992; 90: 150-155.
8. Bosma PJ et al. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 1994; 269: 17960-17964.
9. Seppen J et al. Bilirubin glucuronidation by intact Gunn rat fibroblasts expressing bilirubin UDP-glucuronosyltransferase. Biochem J 1996; 314: 477-483.
10. Askari F et al. Retrovirus-mediated expression of HUG Br1 in Crigler-Najjar syndrome type I human fibroblasts and correction of the genetic defect in Gunn rat hepatocytes. Gene Therapy 1995; 2: 203-208.
11. Yeary R, Grothaus R. The Gunn rat as an animal model in comparative medicine. Lab An Sci 1971; 21: 362-366.
12. Fox IJ et al. Conditional immortalisation of Gunn rat hepatocytes: an ex vivo model for evaluating methods for bilirubin-UDP-glucuronosyltransferase gene transfer. Hepatology 1995; 21 837-846.
13. Takahashi M et al. Long-term correction of bilirubin-UDP-glucuronosyl transferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period. J Biol Chem 1996; 271: 26536-26542.
14. Ilan Y et al. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long gene expression. Proc Natl Acad Sci USA 1997; 94: 2587-2592.
15. Askari F et al. Complete correction of hyperbilirubmemia in the Gunn rat model of Crigler-Najjar syndrome type 1 following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase. Gene Therapy 1996; 2: 203-208
16. Fortunati E et al. In vitro and in vivo gene transfer to pulmonary cells mediated by cationic liposomes. Biochim Biophys Acta 1996; 1306: 55-62.
17. Wilke M et al. Efficacy of a peptide based gene delivery system depends on mitotic activity. Gene Therapy 1996; 2: 1133-1142
18. Zabner J et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995; 270: 18997-19007.
19. Labat-Moleur F et al. An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Therapy 1996; 3: 1010-1017.
20. Andersson S et al. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem 1989; 264: 8222-8229.
21. Jarnagin W et al. Cationic lipid-mediated transfection of liver cells in primary culture. Nucleic Acids Res 1992; 20: 4205-4211.
22. Watanabe Y et al. Highly efficient transfection into primary cultured mouse hepatocytes by use of cation liposomes: an application for immunization. J Biochem 1994; 116: 1220-1226.
23. Somasundaram C et al. Increased efficiency of gene transfection in primary cultures of adult rat hepatocytes stimulated to proliferate: a comparative study using the lipofectin and calcium phosphate precipitate methods. Cell Biol Int Rep 1992; 16: 653-662
24. Baribault H, Leroux-Nicollet I, Marceau N. Differential responsiveness of cultured suckling and adult rat hepatocytes to growth-promoting factors: entry into S phase and mitosis. J Cell Physiol 1985; 122: 105-112.
25. Nakamura T, Tomita Y, Ichihara A. Density-dependent growth control of adult rat hepatocytes in primary culture. J Biochem 1983; 94: 1029-1035.
26. Armato U, Draghi E, Andreis PG. Effect of glucagon and insulin on the growth of neonatal rat hepatocytes in primary tissue culture. Endocrinology 1978; 102: 1155-1166.
27. Bosnia PJ et al. A mutation in bilirubin uridine 5′-diphosphateglucuronosyl transferase isoform 1 causing Crigler-Najjar syndrome type II (see comments). Gastroenterology 1993; 105: 216-220.
28. Chowdhury NR et al. Microtubular disruption prolongs the expression of human bilirubin-uridinediphosphoglucuronate-glucuronosyltransferase-1 gene transferred into Gunn rat livers. J Biol Chem 1996; 271: 2341-2346.
29. Bosch A et al. Proliferation induced by keratinocyte growth factor enhances in vivo retrovirus-mediated gene transfer to mouse hepatocytes. J Clin Invest 1996, 98: 2683-2687.
30. Huang MT, Gorman CM. Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA Nucleic Acids Res 1990; 18: 937-947.
31. Liu X, Mertz JE. HnRNP L binds a cis-acting RNA sequence element that enables intron-dependent gene expression. Gene Dev 1995; 9: 1766-1780.
32. Seglen P. Preparation of isolated rat liver cells. Meth Cell Biol 1975; 13: 29-83.
33. Berry M, Friend D. Preparation of rat liver parenchymal cells. J Clin Biol 1969; 43: 506-520.
34. Enat R et al. Hepatocyte proliferation in vitro: its dependence on the use of serum-free hormonally defined medium and substrata of extracellular matrix. Proc Natl Acad Sci USA 1984; 81: 1411-1415.
35. Kwekkeboom J et al. Cholesterol 7 alpha-hydroxylase activity and bile acid synthesis in hepatocytes of unweaned and weaned pigs in monolayer culture Biochim Biophys Acta 1990; 1042: 386-394.
36. Bout A, Valerio D, Scholte B. In vivo transfer and expression of the lacZ gene in the mouse lung. Exp Lung Res 1993; 19: 193-202
37. Sanes J, Rubenstein JLR, Nicolas J. Use of recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J 1986; 5: 3133-3142.
38. Peters W et al. Characterisation and tissue specificity of a monoclonal antibody against human uridine 5′-diphosphate glucuronosyltransferase. Gastroenterology 1987; 93: 162-169.
39. Spivak W. Bilirubin metabolism. Pediatr Ann 1985; 14: 451-457.
40. Muraca M, Blanckart N. Liquid-chromatographic assay and identification of mono and diester conjugates of bilirubin in normal serum. Clin Chem 1983; 29: 1767-1771.